0
Endo-ERN Publications Database
1008 publication(s) found matching the search criteria
An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia
Author(s):
van’t Westeinde A, Karlsson L, Messina V, Wallensteen L, Brösamle M, Dal Maso G, Lazzerini A, Kristensen J, Kwast D, Tschaidse L, Auer MK, Nowotny HF, Persani L, Reisch N, Lajic S
Affiliated Institution / ERN:
IRCCS Auxologico Italian Institute - Milan ; Klinikum der Universität München ;
Condition / Disease:
Congenital Adrenal Hyperplasia
Publication:
Endocrine Connections Volume 12: Issue 4
Year:
2023
ORPHAcode / other:
ORPHA418
DOI:
10.1530/ec-22-0400
Keywords:
CAH,brain development,dexamethasone,first trimester,prenatal treatment,treatment safety
An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia
Author(s):
van’t Westeinde A, Karlsson L, Messina V, Wallensteen L, Brösamle M, Dal Maso G, Lazzerini A, Kristensen J, Kwast D, Tschaidse L, Auer MK, Nowotny HF, Persani L, Reisch N, Lajic S
Affiliated Institution / ERN:
Karolinska University Hospital ; Charité Universitätsmedizin Berlin ; Aarhus University Hospital ; Antonio Cardarelli Hospital - Naples ;
Condition / Disease:
Congenital Adrenal Hyperplasia
Publication:
Endocrine Connections v12.4
Year:
2023
ORPHAcode / other:
ORPHA418
DOI:
10.1530/EC-22-0400
Keywords:
CAH,brain development,dexamethasone,first trimester,prenatal treatment,treatment safety
Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis
Author(s):
Ertl D, Mantovani G, de Nanclares GP, Elli FM, Pereda A, Pagnano A, Sanchis A, Cueto-Gonzalez AM, Berrade S, León MC, Rothenbuhler A, Audrain C, Berkenou J, Knight N, Dolman K, Gleiss A, Argente J, Linglart A
Affiliated Institution / ERN:
Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ;
Condition / Disease:
Acrodysostosis Type 2 (iPPSD5)
Publication:
Journal of Endocrinological Investigation v46.8 p1673-1684
Year:
2023
ORPHAcode / other:
ORPHA950
DOI:
10.1007/s40618-023-02026-2
Keywords:
Acrodysostosis,Auxology,Inactivating PTH/PTHrP signaling disorders,Pediatric,Recombinant human growth hormone,SGA,Short stature
Prader–Willi syndrome: Symptoms and topiramate response in light of genetics
Author(s):
Louveau C, Turtulici M, Consoli A, Poitou C, Coupaye M, Krebs M, Chaumette B, Iftimovici A
Affiliated Institution / ERN:
Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease:
Prader Willi syndrome
Publication:
Frontiers in Neuroscience v17
Year:
2023
ORPHAcode / other:
ORPHA739
DOI:
10.3389/fnins.2023.1126970
Keywords:
Prader–Willi,deletion,disomy,genetics,personalized medicine,topiramate,treatment
Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol
Author(s):
Clement SC, Visser WE, Lebbink CA, Albano D, Claahsen-van der Grinten HL, Czarniecka A, Dias RP, Dierselhuis MP, Dzivite-Krisane I, Elisei R, Garcia-Burillo A, Izatt L, Kanaka-Gantenbein C, Krude H, Lamartina L, Lorenz K, Luster M, Navardauskaitė R, Negre Busó M, Newbold K, Peeters RP, Pellegriti G, Piccardo A, Priego AL, Redlich A, de Sanctis L, Sobrinho-Simões M, van Trotsenburg ASP, Verburg FA, Vriens M, Links TP, Ahmed SF, van Santen HM
Affiliated Institution / ERN:
Unidade Local de Saúde de Santa Maria(ULS de Santa Maria) ; University Medical Center Groningen ; University Medical Center Utrecht ; Amsterdam UMC ; Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; Aghia Sophia Children’s Hospital ; Charité Universitätsmedizin Berlin ; AO City of Health and Science - Turin ;
Condition / Disease:
Pediatric Thyroid cancer
Publication:
Endocrine Connections Volume 12: Issue 3
Year:
2023
ORPHAcode / other:
ORPHA146
Prospective evaluation of multidimensional health‐related quality of life after endoscopic endonasal surgery for pituitary adenomas using the endoscopic endonasal sinus and skull base surgery questionnaire
Author(s):
Joustra GE, ten Dam E, Vermeulen KM, Korsten‐Meijer AGW, Appelman APA, Feijen RA
Affiliated Institution / ERN:
University Medical Center Groningen ;
Condition / Disease:
Acromegaly
Publication:
Laryngoscope Investigative Otolaryngology v8.1 p7-15
Year:
2023
ORPHAcode / other:
ORPHA963
DOI:
10.1002/lio2.1004
Keywords:
anterior skull base,endoscopic endonasal sinus and Skull Base surgery questionnaire (EES‐Q),endoscopic skull base surgery,patient reported outcome measure,quality of life
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion: know the condition and do not mistake for adenoma
Author(s):
Grzywotz A, Li Y, Unger N, Kiewert C, Chmielewski WX, Sure U, Uerschels A, Wrede K, Kreitschmann-Andermahr I
Affiliated Institution / ERN:
University Hospital Essen ;
Condition / Disease:
Pituitary adenoma
Publication:
Pituitary v26.1 p164-170
Year:
2023
ORPHAcode / other:
ORPHA99408
DOI:
10.1007/s11102-022-01296-y
Keywords:
CSF pressure,ICP,Pituitary enlargement,Pituitary hyperplasia,Shunt insertion
Teplizumab approval for type 1 diabetes in the USA
Author(s):
Beran D, Abidha C, Adler A, de Beaufort C, Lepeska M, Levitt N, Pfiester E, Zafra-Tanaka JH, Gale EA
Affiliated Institution / ERN:
Centre Hospitalier de Luxembourg ;
Condition / Disease:
diabetes type 1; Teplizumab;
Publication:
The Lancet Diabetes & Endocrinology v11.2 p78-80
Year:
2023
ORPHAcode / other:
Fluctuations in Thyroid Hormone Levels During Initial Treatment for Differentiated Thyroid Carcinoma are Associated with Changes in Hemostasis: A Prospective Cohort Study
Author(s):
Links MH, Lefrandt JD, Lisman T, van der Boom T, Lukens MV, Meijer K, Links TP, Zandee WT
Affiliated Institution / ERN:
University Medical Center Groningen ;
Condition / Disease:
Thyroid cancer
Publication:
Thyroid v33.2 p203-213
Year:
2023
ORPHAcode / other:
ORPHA146
DOI:
10.1089/thy.2022.0299
Keywords:
TH withdrawal,THST,cardiovascular risk,differentiated thyroid carcinoma,hemostasis,thrombosis
Effects of treatment for diabetes mellitus on testosterone concentrations: A systematic review
Author(s):
Van Cauwenberghe J, De Block C, Vanderschueren D, Antonio L
Affiliated Institution / ERN:
UZ Antwerpen ;
Condition / Disease:
testosterone and diabetes
Publication:
Andrology v11.2 p225-233
Year:
2023
ORPHAcode / other:
DOI:
10.1111/andr.13318
Keywords:
GLP1 receptor analogues,antidiabetic agents,antihyperglycemic agents,functional hypogonadism,hypogonadism,obesity
Continuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial
Author(s):
Battelino T, Danne T, Edelman SV, Choudhary P, Renard E, Westerbacka J, Mukherjee B, Pilorget V, Coudert M, Bergenstal RM
Affiliated Institution / ERN:
University Medical Centre Ljubljana ;
Condition / Disease:
Diabetes mellitus
Publication:
Diabetes, Obesity and Metabolism v25.2 p545-555
Year:
2023
ORPHAcode / other:
DOI:
10.1111/dom.14898
Keywords:
basal insulin,continuous glucose monitoring,glycaemic control,insulin analogues,randomized trial,type 1 diabetes
In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression
Author(s):
Bugalho MJ, Lopes-Pinto M, Lemos C, Nobre E
Affiliated Institution / ERN:
Unidade Local de Saúde de Santa Maria(ULS de Santa Maria) ;
Condition / Disease:
Acromegaly
Publication:
Cureus doi:10.7759/cureus.34463
Year:
2023
ORPHAcode / other:
ORPHA963
DOI:
10.7759/cureus.34463
Keywords:
acromegaly,growth hormone,hyperglycemia,oral glucose tolerance test,suppression test
Adherence to Acromegaly Treatment and Analysis of the Related Factors—A Real-World Study in Bulgaria
Author(s):
Kamusheva M, Vandeva S, Mitov K, Parvanova A, Pesheva M, Ganov N, Rusenova Y, Marinov L, Getova V, Elenkova A, Petrova G
Affiliated Institution / ERN:
USHATE “ACAD IVAN Penchev” ;
Condition / Disease:
Acromegaly
Publication:
Pharmaceutics v15.2 p438
Year:
2023
ORPHAcode / other:
ORPHA963
Multicentric Italian case–control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome
Author(s):
Panfili FM, Convertino A, Grugni G, Mazzitelli L, Bocchini S, Crinò A, Campana G, Cappa M, Delvecchio M, Faienza MF, Licenziati MR, Mariani M, Osimani S, Pajno R, Patti G, Rutigliano I, Sacco M, Scarano E, Fintini D
Affiliated Institution / ERN:
AOU-Bologna ;
Condition / Disease:
Prader-Willi syndrome
Publication:
Journal of Endocrinological Investigation v46.7 p1397-1406
Year:
2023
ORPHAcode / other:
ORPHA739
DOI:
10.1007/s40618-022-01990-5
Keywords:
25OHD,GH therapy,Insulin resistance,Obesity,Prader-Willi syndrome,Vitamin D
Multicentric Italian case–control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome
Author(s):
Panfili FM, Convertino A, Grugni G, Mazzitelli L, Bocchini S, Crinò A, Campana G, Cappa M, Delvecchio M, Faienza MF, Licenziati MR, Mariani M, Osimani S, Pajno R, Patti G, Rutigliano I, Sacco M, Scarano E, Fintini D
Affiliated Institution / ERN:
San Raffaele hospital - Milan ;
Condition / Disease:
Prader-Willi syndrome
Publication:
Journal of Endocrinological Investigation v46.7 p1397-1406
Year:
2023
ORPHAcode / other:
ORPHA739
DOI:
10.1007/s40618-022-01990-5
Keywords:
25OHD,GH therapy,Insulin resistance,Obesity,Prader-Willi syndrome,Vitamin D
Mapping of the current transition of care practice for patients with pituitary disease at Endo-ERN reference centers
Author(s):
Shishkov SR, Tuccillo L, Iotova VM, Pivonello R, Pelsma IC, Pereira AM, Biermasz NR, and the Endo-ERN Reference Centers of the Main Thematic Group: Hypothalmic and Pituitary Conditions, Endo-ERN Pituitary Transition of Care Study Group
Affiliated Institution / ERN:
UMHAT “Sveta Marina” (Varna) ; Leiden University Medical Center ;
Condition / Disease:
pituitary conditions; transition survey;
Publication:
Endocrine Connections Volume 12: Issue 2
Year:
2023
ORPHAcode / other:
ORPHA99408; ORPHA95502
DOI:
10.1530/ec-22-0308
Keywords:
Endo-ERN,pituitary disease,quality of care,survey,transition of care
Methylation status of hypothalamic Mkrn3 promoter across puberty
Author(s):
Fanis P, Morrou M, Tomazou M, Michailidou K, Spyrou GM, Toumba M, Skordis N, Neocleous V, Phylactou LA
Affiliated Institution / ERN:
Cyprus Institute of Neurology and Genetics ;
Condition / Disease:
Central Precocious Puberty
Publication:
Frontiers in Endocrinology v13
Year:
2023
ORPHAcode / other:
ORPHA650182
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome
Author(s):
Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, Brunet J, Lleuger-Pujol R, Høberg-Vetti H, Tveit Haavind M, Innella G, Turchetti D, Aretz S, Spier I, Tischkowitz M, Jahn A, Links TP, Olderode-Berends MJW, Blatnik A, Leter EM, Evans DG, Woodward ER, Steinke-Lange V, Anastasiadou VC, Colas C, Villy M, Benusiglio PR, Gerasimenko A, Barili V, Branchaud M, Houdayer C, Tesi B, Yazicioglu MO, van der Post RS, Schuurs-Hoeijmakers JHM, van Hest LP, Adank MA, Duijkers F, Nielsen M, Verbeek KCJ, van Ierland Y, Giltay JC, Vos JR, Vos JR
Affiliated Institution / ERN:
University Medical Center Groningen ;
Condition / Disease:
Familial Genetic Tumour Syndromes
Publication:
JNCI: Journal of the National Cancer Institute v115.1 p93-103
Year:
2023
ORPHAcode / other:
ORPHA306498
Pre-Surgery Patient Health Contributes to Aggravated Sino-Nasal Outcome and Quality of Life after Pituitary Adenomectomy
Author(s):
Chmielewski WX, Walbrodt S, Rauschenbach L, Chihi M, Gembruch O, Darkwah Oppong M, Schroer S, Wrede KH, Dammann P, Jabbarli R, Kreitschmann-Andermahr I, Sato T, Unger N, Mattheis S, Sure U, Ahmadipour Y
Affiliated Institution / ERN:
University Hospital Essen ;
Condition / Disease:
pituitary adenoma
Publication:
Medicina v59.1 p127
Year:
2023
ORPHAcode / other:
ORPHA99408
DOI:
10.3390/medicina59010127
Keywords:
adenomectomy,health-related quality of life,pituitary adenoma,pre-surgery patient health,sino-nasal health
Pediatric growth hormone and prolactin-secreting tumor associated with an AIP mutation and a MEN1 variant of uncertain significance
Author(s):
Alexandre MI, Faria CC, Gomes A, Bugalho MJ
Affiliated Institution / ERN:
Unidade Local de Saúde de Santa Maria(ULS de Santa Maria) ;
Condition / Disease:
Pediatric growth hormone and prolactin secreting tumour
Publication:
Journal of Pediatric Endocrinology and Metabolism v0.0
Year:
2023
ORPHAcode / other:
ORPHA2965
Deescalating Follow-up After Hemithyroidectomy for Patients With Low-risk Papillary Thyroid Microcarcinoma
Author(s):
van Dijk SPJ, Coerts HI, Lončar I, Verhoef C, Kruijff S, Engelsman AF, Peeters RP, van Ginhoven TM
Affiliated Institution / ERN:
University Medical Center Groningen ;
Condition / Disease:
Follicular thyroid carcinoma
Publication:
JAMA Otolaryngology–Head & Neck Surgery v149.1 p42
Year:
2023
ORPHAcode / other:
ORPHA146
Type 1 diabetes mellitus prevention
Author(s):
Groele L, Szypowska A
Affiliated Institution / ERN:
Public Pediatric Teaching Hospital ;
Condition / Disease:
diabetes type 1
Publication:
Pediatric Endocrinology Diabetes and Metabolism v29.4 p209-213
Year:
2023
ORPHAcode / other:
Multi-omic integration reveals cell-type-specific regulatory networks of insulin resistance in distinct ancestry populations
Author(s):
Xu P, Wang M, Sharma NK, Comeau ME, Wabitsch M, Langefeld CD, Civelek M, Zhang B, Das SK
Affiliated Institution / ERN:
Ulm University Medical Center ;
Condition / Disease:
Insulin-resistance syndrome
Publication:
Cell Systems v14.1 p41-57.e8
Year:
2023
ORPHAcode / other:
ORPHA181368
DOI:
10.1016/j.cels.2022.12.005
Keywords:
African American,European American,adipose,eQTL,gene causal network,gene co-expression network,gene module,insulin resistance,key driver,muscle
Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma
Author(s):
Koot A, Soares P, Robenshtok E, Locati LD, de la Fouchardiere C, Luster M, Bongiovanni M, Hermens R, Ottevanger P, Geenen F, Bartѐs B, Rimmele H, Durante C, Nieveen-van Dijkum E, Stalmeier P, Dedecjus M, Netea-Maier R
Affiliated Institution / ERN:
Amsterdam UMC ; São João University Hospital(CHUSJ) ;
Condition / Disease:
papillary thyroid carcinoma
Publication:
European Journal of Cancer v179 p98-112
Year:
2023
ORPHAcode / other:
ORPHA146
DOI:
10.1016/j.ejca.2022.11.005
Keywords:
Microcarcinoma,Papillary,Shared decision making,Thyroid,Treatment options
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Author(s):
Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M
Affiliated Institution / ERN:
University Medical Centre Ljubljana ;
Condition / Disease:
Continuous glucose monitoring
Publication:
The Lancet Diabetes & Endocrinology v11.1 p42-57
Year:
2023
ORPHAcode / other:
Pubertal and Gonadal Outcomes in 46,XY Individuals with Partial Androgen Insensitivity Syndrome Raised as Girls
Author(s):
Guaragna-Filho G, Guerra-Junior G, Tadokoro-Cuccaro R, Hughes IA, Barros BA, Hiort O, Balsamo A, Guran T, Holterhus PM, Hannema S, Poyrazoglu S, Darendeliler F, Bryce J, Ahmed SF, Quigley CA
Affiliated Institution / ERN:
Universitätsklinikum Schleswig-Holstein ;
Condition / Disease:
Partial androgen insensitivity syndrome
Publication:
Sexual Development v17.1 p16-25
Year:
2023
ORPHAcode / other:
ORPHA754; ORPHA90797;
DOI:
10.1159/000526997
Keywords:
Androgen insensitivity syndrome,Differences of sex development,Disorders of sex development,Partial androgen insensitivity syndrome,Puberty
Challenges Waiting for an Adult with DSD
Author(s):
Nowotny HF, Reisch N
Affiliated Institution / ERN:
Klinikum der Universität München ;
Condition / Disease:
DSD
Publication:
Hormone Research in Paediatrics v96.2 p207-221
Year:
2023
ORPHAcode / other:
ORPHA98085; ORPHA2982; ORPHA325546;
DOI:
10.1159/000527433
Keywords:
46,XY DSD,Adult care,Androgen insensitivity syndrome,Comorbidities,Congenital adrenal hyperplasia,Disorders/differences of sex development,Gonadal dysgenesis,Klinefelter syndrome,Long-term outcome,Transition,Turner syndrome
Testicular Architecture of Men with 46,XX Testicular Disorders of Sex Development
Author(s):
Hiort M, Rohayem J, Knaf R, Laurentino S, Berglund A, Gravholt CH, Gromoll J, Wistuba J
Affiliated Institution / ERN:
Aarhus University Hospital ;
Condition / Disease:
46XX Testicular Disorders of Sex Development
Publication:
Sexual Development v17.1 p32-42
Year:
2023
ORPHAcode / other:
ORPHA325546
Growth Hormone Dose Modulation and Final Height in Short Children Born Small for Gestational Age: French Real-Life Data
Author(s):
Coutant R, Leheup B, Nicolino M, Salles J
Affiliated Institution / ERN:
CHU d'Angers ;
Condition / Disease:
Growth Hormone Dose Modulation
Publication:
Hormone Research in Paediatrics v96.5 p495-508
Year:
2023
ORPHAcode / other:
ORPHA90692; ORPHA631;
DOI:
10.1159/000530572
Keywords:
Dose modulation,Growth hormone,Real-world data,Small for gestational age
Abstracts of the 2023 Pediatric Endocrine Society (PES) Annual Meeting’ to Hormone Research in Paediatrics
Author(s):
Program Chairs, PES 2023 Annual Meeting Dr. Leena Nahata, Columbus, OH Dr. Takara Stanley, Boston, MA
Affiliated Institution / ERN:
Beaumont & CHI - Dublin ;
Condition / Disease:
growth hormone deficiency
Publication:
Hormone Research in Paediatrics v96.Suppl. 3 p1-399
Year:
2023
ORPHAcode / other:
ORPHA101957; ORPHA95488
